Assembly Biosciences ASMB
NASDAQ ASMB
$19.84 -0.44 (-2.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Amortization of Deferred Charges (2010 - 2011)

Updated

Analysis

Assembly Biosciences (ASMB) Amortization of Deferred Charges (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Assembly Biosciences 373.11 Mn -654.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 279,933.00
Jun 30, 2011 24,512.00
Dec 31, 2010 19,909.00
Sep 30, 2010 402,574.00
Jun 30, 2010 784,787.00
API Access

Assembly Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ASMB&period=max&api_key=YOUR_API_KEY